MENU
QLGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Qualigen Therapeutics (QLGN) Ownership - Who owns Qualigen Therapeutics?
Profile
Industry
N/A
Address
5857 Owens Avenue
Phone
+1 760 452-8111
Employees
4
Web
https://www.qlgntx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.67M
P/E Ratio
N/A
Total Cash
401.8K
Projected Growth
N/A
Total Debt
1.3M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
QLGN
Capitalization
4.68M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
402K
Total Cash/Share
0.01
Total Debt
1.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
-2.1M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
43.3K
Current Ratio
0.28
Current Revenue Per Employee
42816.61
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
37.52
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
27M
Total Liabilities
4.14M
Total Volume MTD
N/A
Value
1
Gain YTD
-66.073
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company which focused on developing therapeutics for the treatment of cancer and infectious diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5857 Owens Avenue
Phone
+1 760 452-8111
Employees
4
Web
https://www.qlgntx.com